Werewolf Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 1.41 M | $892.70 M | 0.00% | 3.10% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.39 M | $883.52 K | -42.15% | 3.06% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 737.55 K | $466.87 M | -59.70% | 1.62% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 677.77 K | $429.37 K | 48.63% | 1.49% |
| DC FUNDS, LP | 02/13/2026 | 589.10 K | $373.20 K | 0.00% | 1.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 335.89 K | $212.84 M | 1.54% | 0.74% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 240.11 K | $152.11 K | -24.27% | 0.53% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 235.71 K | $149.32 K | 0.00% | 0.52% |
| JANE STREET GROUP, LLC | 02/12/2026 | 157.32 K | $99.66 M | -41.42% | 0.35% |
| STATE STREET CORP | 02/13/2026 | 119.17 K | $75.49 K | 0.00% | 0.26% |
| BLACKROCK, INC. | 02/12/2026 | 101.64 K | $64.39 K | 0.32% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 99.83 K | $63.24 K | 7.30% | 0.22% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 77.00 K | $48.78 K | -24.51% | 0.17% |
| UBS GROUP AG | 01/29/2026 | 60.71 K | $38.43 K | 375.17% | 0.13% |
| VONTOBEL HOLDING LTD. | 02/13/2026 | 60.00 K | $38.01 K | 66.68% | 0.13% |
| REGAL INVESTMENT ADVISORS LLC | 02/17/2026 | 52.59 K | $33.32 K | 93.33% | 0.12% |
| EDGEWOOD MANAGEMENT LLC | 02/12/2026 | 50.00 K | $31.68 K | 0.00% | 0.11% |
| MORGAN STANLEY | 02/13/2026 | 46.00 K | $29.14 K | 138.95% | 0.10% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 34.07 K | $21.59 M | -43.53% | 0.07% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 24.05 K | $15.25 K | 53.84% | 0.05% |
| CERTUITY, LLC | 01/30/2026 | 15.00 K | $9.50 K | 0.00% | 0.03% |
| DELTA INVESTMENT MANAGEMENT, LLC | 01/30/2026 | 14.93 K | $9.46 K | 100.00% | 0.03% |
| BARCLAYS PLC | 02/13/2026 | 13.24 K | $8.39 K | -0.29% | 0.03% |
| HBK SORCE ADVISORY LLC | 02/09/2026 | 13.23 K | $8.10 K | 0.00% | 0.03% |
| LARSON FINANCIAL GROUP LLC | 02/06/2026 | 13.05 K | $8.27 K | 30.52% | 0.03% |
| RANCH CAPITAL ADVISORS INC. | 02/05/2026 | 12.00 K | $7.60 K | 100.00% | 0.03% |
| HIGHLINE WEALTH PARTNERS LLC | 01/15/2026 | 12.00 K | $7.60 K | 140.00% | 0.03% |
| STONEX GROUP INC. | 02/12/2026 | 10.51 K | $6.66 K | 100.00% | 0.02% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 10.30 K | $6.53 K | -70.23% | 0.02% |
| CETERA INVESTMENT ADVISERS | 02/17/2026 | 10.20 K | $6.46 K | 0.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 8.63 K | $5.43 K | -10.39% | 0.02% |
| FINANCIAL PERSPECTIVES, INC | 01/28/2026 | 6.75 K | $4.28 K | 0.00% | 0.01% |
| TFC FINANCIAL MANAGEMENT, INC. | 01/23/2026 | 4.50 K | $2.85 K | 80.00% | 0.01% |
| FEDERATED HERMES, INC. | 02/12/2026 | 4.39 K | $2.78 K | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 2.07 K | $1.31 K | 84.51% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 1.87 K | $1.19 K | -29.95% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 792 | $502 | -0.13% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/15/2026 | 345 | $219 | -74.91% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 40 | $25 | -2.44% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/13/2026 | 39 | $25 | -42.65% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/10/2026 | 4 | $3 | 100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1 | $1 | -99.99% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| PLANTE MORAN FINANCIAL ADVISORS, LLC | 02/05/2026 | 0 | $0 | -100.00% | 0.00% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Werewolf Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 65 institutional investors and hedge funds held shares of Werewolf Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.41 M
BioImpact Capital LLC: 1.39 M
BANK OF AMERICA CORP /DE/: 737,550
RENAISSANCE TECHNOLOGIES LLC: 677,766
GEODE CAPITAL MANAGEMENT, LLC: 335,886
MILLENNIUM MANAGEMENT LLC: 240,109
7.04% of Werewolf Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 11.89 M shares in the last 24 months. This purchase volume represents approximately $8.56 M in transactions.